X
Xiao-Yang Qiao
Researcher at Xiamen University
Publications - 5
Citations - 183
Xiao-Yang Qiao is an academic researcher from Xiamen University. The author has contributed to research in topics: Neutralization & Antigen. The author has an hindex of 4, co-authored 4 publications receiving 94 citations.
Papers
More filters
Journal ArticleDOI
Robust neutralization assay based on SARS-CoV-2 S-protein-bearing vesicular stomatitis virus (VSV) pseudovirus and ACE2-overexpressing BHK21 cells.
Hualong Xiong,Yangtao Wu,Jiali Cao,Ren Yang,Yingxia Liu,Jian Ma,Xiao-Yang Qiao,Xiang-Yang Yao,Bao-Hui Zhang,Yali Zhang,Wangheng Hou,Yang Shi,Jingjing Xu,Liang Zhang,Shaojuan Wang,Baorong Fu,Ting Yang,Shengxiang Ge,Jun Zhang,Quan Yuan,Baoying Huang,Zhiyong Li,Tianying Zhang,Ningshao Xia +23 more
TL;DR: In this study, a G protein-deficient vesicular stomatitis virus (VSVdG) bearing a truncated spike protein was compared to that bearing the full-length spike protein of SARS-CoV-2 and showed much higher efficiency and could facilitate the development of new drugs and vaccines.
Journal ArticleDOI
A unique B cell epitope-based particulate vaccine shows effective suppression of hepatitis B surface antigen in mice
Tianying Zhang,Guo Xueran,Yangtao Wu,Xiao-Zhen Kang,Qingbing Zheng,Ruoyao Qi,Bin-Bing Chen,Ying Lan,Min Wei,Shaojuan Wang,Hualong Xiong,Jiali Cao,Bao-Hui Zhang,Xiao-Yang Qiao,Xiaofen Huang,Yingbin Wang,Mujin Fang,Yali Zhang,Tong Cheng,Yixin Chen,Qinjian Zhao,Shaowei Li,Shengxiang Ge,Pei-Jer Chen,Jun Zhang,Quan Yuan,Ningshao Xia +26 more
TL;DR: The novel particulate protein CR-T3-SEQ13 suppressed HBsAg effectively through induction of a humoural immune response in HBV-tolerant mice and may provide a novel immunotherapeutic agent against chronic HBV infection in humans.
Posted ContentDOI
Robust neutralization assay based on SARS-CoV-2 S-bearing vesicular stomatitis virus (VSV) pseudovirus and ACE2-overexpressed BHK21 cells
Hualong Xiong,Yangtao Wu,Jiali Cao,Ren Yang,Jian Ma,Xiao-Yang Qiao,Xiang-Yang Yao,Bao-Hui Zhang,Yali Zhang,Wangheng Hou,Yang-Shi,Jingjing Xu,Liang-Zhang,Shaojuan Wang,Baorong Fu,Ting Yang,Shengxiang Ge,Jun Zhang,Quan Yuan,Baoying Huang,Zhiyong Li,Tianying Zhang,Ningshao Xia +22 more
TL;DR: The serum neutralizing titer of COVID-19 convalescent patients measured by VSV-SARS-CoV-2-Sdel18 pseudovirus assay has a good correlation with live SARS- covirus assay, which could facilitate the development of new drugs and vaccines.
Journal ArticleDOI
Several FDA-Approved Drugs Effectively Inhibit SARS-CoV-2 Infection in vitro
Hualong Xiong,Jia-Li Cao,Jia-Li Cao,Chenguang Shen,Jian Ma,Xiao-Yang Qiao,Tian-Shu Shi,Shengxiang Ge,Hui-Ming Ye,Jun Zhang,Quan Yuan,Tianying Zhang,Ningshao Xia +12 more
TL;DR: In this article, the potency of 1403 FDA-approved drugs were evaluated using a robust pseudovirus assay and the candidates were further confirmed by authentic SARS-CoV-2 assay.